Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5200_Библиотеки_им_академика_М_И_Перельмана
.pdf
Batheregularly.
Avoidscratching.
Avoidirritants,includingtightclothingandocclusivecosmeticsanddeodorants.
Avoidreusingorsharingpersonalitemssuchasdisposablerazors,towels,andbedsheets.
Disinfectcommonlytouchedsurfacessuchasdoorknobs,counters,andtoiletseats.
Lipsky,B.A.,Berendt,A.R.,Cornia,P.B.,etal.2012InfectiousDiseasesSocietyofAmericaclinicalpracticeguidelineforthediagnosis
andtreatmentofdiabeticfootinfections.ClinicalInfectiousDiseases:AnOfficialPublicationoftheInfectiousDiseasesSocietyof
America,54(12),e132–e173.
Inmanycases,systemicantibiotictherapy(Table13.4)isprescribedempiricallybasedonknowledge
oftheorganismscommonlyresponsibleforspecificskininfections,suchasS.aureusandGAS.Therapy
isthennarrowedoncecultureresults,ifcollected.
In the case of puncture or bite wounds that are not initially infected, antibiotics are prescribed as
prophylaxis in immunocompromised individuals because of the high risk of infection associated with
thesewounds(Box13.1).
Topical medications, suchas mupirocin (Bactroban) ointment, can be occasionally used as primary
therapyforminorinfections(e.g.,impetigo)oralternativelyusedincombinationwithsystemicagentsfor
moreseriousinfections.InsomepatientsthoughttobechroniccarriersofS.aureus,infectionsmaybe
recurrent.
Severalotheradjunctivemeasuresmayalsobeusedincombinationwithdrugtherapy.Bedsidewarm
soaksandincisionanddrainageproceduresmayhelpresolvepustularlesions.Patientswithaparonychia
may need to have the nail bed decompressed to relieve the pressure, and deeper and more invasive
infectionsalmostalwaysrequireincisionanddrainage.
GoalsofDrugTherapy
The goals in treating bacterial skin infections are to cure the infection, prevent worsening, minimize
scarring,andpreventrecurrence.Manyminorinfectionsresolvewithin10to14days.Ifresolutiondoes
notoccur,alternative agentsmay be prescribed.Theprescriber mustdecidewhenit is appropriateto
initiate treatment with an alternative agent or whether a referral to a specialist for more definitive
diagnosisandtreatmentisindicated.
TABLE13.4
OverviewofSelectedAntibioticsforSkinInfections

Generic
Dosage
and
-
Broad
Spectrum
(
Trade)Name
Penicillins
Selected
Adverse
Events
Contraindications
Special
Considerations
Amoxicillin—clavulanate
Augmentin
(
Adults
:
Children
basedonthe
Dicloxacillin
Adults
:
Children
q
PO
-
First
Generation
Cephalexin
Adults
:
Children
divided
Cefazolin(Ancef
Adults
:
Children
)
500
875
-
weight
:
Dynapen
(
125-250
6.25-12.5
:
6
h
(
Keflex
mg
500
25-50
:
3
in
-
g
q
:
50
IV
8
mg
1
mg
q
12
h
-
PO
4
)
dosing
based
formulation
)
mg
mg
q
PO
/
mg
kg
Cephalosporins
)
q
6
h
/
kg
/
d
doses
h
d
/kg/
divided
IV
into3doses
vomiting
Nausea
Serious
,
,
allergic
rash
infection
:
colitis,seizures
as
Same
6
h
Nausea
Serious
amoxicillin—clavulanate
vomiting
,
,
allergic
rash
infections
:
colitis,seizures
cephalexin
as
Same
,
diarrhea
reactions
,
,
fungal
Pseudomembranous
(
high
,
diarrhea
reactions
doses
,
fungal
,
)
Pseudomembranous
(
high
doses
)
Allergy
to
Use
Penicillin
Use
Serious
Use
caution
with
renal
disease,less
allergy
allergy
caution
with
dysfunction
renal
penicillin
allergy
cautioninrenal
with
disease
cephalexin
as
Same
penicillin
severe
in
severe
cephalosporins
to
severe
in
allergy
,
cephalosporins
to
Food
Renal
Comes
.
Interactions
INR
(
decrease
of
Take
absorption
Interactions
(
Decreases
Food
Renal
Same
may
decrease
adjustments
suspension
in
:
)
,
contraceptives
oral
contraceptive
empty
on
:
may
decrease
adjustments
cephalexin
as
Gl
:
warfarin
effectiveness
)
stomach
warfarin
)
INR
Gl
symptoms
for
children
may
(
increase
best
for
symptoms
.
Second-Generation
release
h
release
-
20
40
:
1
(
Cefzil
PO
mg
20
:
mg
mg
15
:
(
mg
(
Rocephin
q
g
24
75
50
:
-
)
250-500
:
500
:
/kg/
mg
g
/
d
)
mg
PO
q
h
24
kg
q
/
24
,
Zinacef
q
PO
12
kg
/
PO
Cephalosporins
)
Vantin
q
PO
h
12
)
g
q
12
h
IMorIV
mg
kg
/
Cefaclor(Ceclor
Adults
:
Immediate
q
PO
8
Extended
q
12
h
Children
exceed
to
Cefprozil
Adults
:
500
250-500
mg
Children
Cefuroxime(Ceftin
Adults
500
:
Children
-
Third
Generation
Cefpodoxime
Adults
Ceftriaxone
Adults
Children
or
or
400
:
0.5-1.0
:
1-2
IV
Cephalosporins
Same
mg
mg
PO
q
d
8
not
h
Same
q
or
12
h
h
)
Same
h
q
h
12
Same
Same
h
IMorIV
q
24
h
IM
pseudolithiasis
cephalexin
as
cephalexin
as
cephalexin
as
cephalexin
as
as
cephalexin
and
also
Same
Same
Same
Same
Same
cephalexin
as
cephalexin
as
cephalexin
as
cephalexin
as
as
cephalexin
cephalexin
as
Same
cephalexin
as
Same
cephalexin
as
Same
whole
becauseofbitter
cephalexin
as
Same
Not
recommended
years
12
<
Dilute
at
renal
with
injection
dose
IM
No
:
pain
;
swallow
taste
children
for
lidocaine
reduce
to
site
adjustments
needed

CPK,creatinephosphokinase;GAS,GroupAstreptococcus:GI,gastrointestinal;IM,Intramuscular;INR,internationalnormalizedratio;IV,
intravenous;MAO,monoamineoxidase;MRSA,methicillin-resistantS.aureus;QTc,correctedQ-Tinterval.
Antibiotics
Severalclassesofantibioticsareusefulfortreatingbacterialskininfections.Forinformationonspecific
agents,refertoTable 13.4. Incertaincircumstances,a combinationofantibioticsmaybe necessaryto
treat an infection because of multiple pathogens (i.e., a polymicrobial infection). Agents may be
Fluoroquinolones
Ciprofloxacin(Cipro
Adults
Levofloxacin
Adults
Moxifloxacin
Adults
Miscellaneous
Clindamycin
Adults
Children
Daptomyein
Adults
Children
:
:
:
:
into
:
500-750
750
400
300
20-40
:
-
3
4
mg
4
not
:
mg
Levaquin
(
mg
/
PO
(
Avelox
mg
/
PO
(
Cleocin
-
mg
450
mg
doses
(
Cubicin
kgIVdaily
/
approved
)
IV
)
IV
P
)
PO
/kg/
)
q
0
)
q
24
q
24
q
d
12
h
h
h
6
h
divided
Nausea,diarrhea,altered
dizziness,drowsiness,head
,
ache,insomnia
confusion
Serious
Nausea
Serious
Pseudomembranous
:
,
Stevens
colitis
syndrome
vomiting
,
allergic
,
rash
infections
Pseudomembranous
:
agitation
hypoglycemia
,
-
Johnson
,
diarrhea
reaction
,
colitis
elevation
CPK
myopathy
or
with
(
reversible
without
)
,
taste
-
,
,
fungal
Allergy
Myasthenia
Children
Use
Allergy
Allergytodaptomyein
fluoroquinolone
to
gravis
younger
,
pregnancy
18
cautioninrenal
with
hepatic
nervous
older
(
lincomycin
children
age
disease,central
system
adults
safety
not
clindamycin
younger
18
established
than
disease
,
lactation
or
,
than
age
.
and
,
)
Black
Food
warning
box
adverse
fluoroquinolones
and
neuropathy
system
ruptures
effects
tendon
effects
slows
about
assxiated
Tendinitis
:
rupture
,
central
,
and
or
tears
absorption
serious
,
peripheral
nervous
aortic
.
Interactions:antacids,zinc
theophylline
,
,
sucralfate
warfarin
glucocorticoids
adjustments
Renal
prolongation
QTc
Take
with
glass
full
esophageal
Check
susceptibility
Monitor
especially
HMG-CoAreductase
iron
,
probenecid
,
didanosine
or
without
of
water
irritation
antibiogram
for
CPK
for
rates
elevations
patients
in
,
foscarnet
food
avoid
to
local
for
MRSA
receiving
inhibitors
with
,
,
,
with
,
Doxycycline(Doxy
Adults
Children
Linezolid
Adults
Children
Tigecycline(Tygacil
Adults
Children
Sulfamethoxazole
Adults
Children
Vancomycin
Adults
Children
100
:
not
:
(
Zyvox
600
:
10
:
100
:
mg
q
50
not
:
(
Bactrim
tablets
component
q
12
:
h
:
1-2
8
:
15
10
:
)
q
mg
100
mg
PO
approved
)
mg
or
IV
mg
kg
/
)
x
mg
1
12
h
approved
trimethoprim
-
-
double
12
h
mg
kg
trimethoprim
/
day
PO
/
(
Vancocin
kg
/
IV
mg
kg
/
q
12
q
dose
strength
q
IV
)
h
q
PO
12
8
h
,
then
divided
)
12
h
q
6
h
Photosensitivity
abdominal
,
diarrhea
pain
,
upper
Pregnancy
Children
8
<
years
No
renal
Unreliable
check
,
marrow
Bone
h
optic
neuropathy
Nausea
headache
marrow
Bone
rash
ing,hyperkalemia
dysfunction
Infusion
man
injury
suppression
neuritis
,
with
vomiting
,
,
hepatic
suppression
,
-
syndrome
,
nausea
related
reactions(red
or
,
diarrhea
and
)
,
rare
peripheral
use
2
>
weeks
,
dysfunction
,
vomit
-
,
renal
phlebitis
,
renal
Allergy
Allergytotigecycline
Allergy
Allergytovancomycin
uncontrolled
tension,and
use
of
use
also
patients
tetracyclines
to
trimethoprim
patients
folate
who
have
severe
prior
from
concurrent
inhibitors
MAO
caution
allergies
with
sulfonamides
,
pregnant
nursing
,
deficiency
developed
thrombocytopenia
therapy
,
-
hyper
Interaction
reuptake
inhibitors
to
Dosage
severe
for
Reserved
coverage
Poor
Requires
;
in
or
mothers,Monitor
or
those
creatinine
Administer
water
adjustments
Renal
.
Monitor
dose
to
Rate
of
man
red
adjustments
dose
streptococcus
antibiogram
local
selective
with
inhibitors
adjustment
hepatic
very
for
renal
potassium
with
and
necessary
is
impairment
resistant
against
adjustments
dose
and
glass
a
full
GAS
levelsorconsult
can
infusion
syndrome
be
occurs
coverage
serotonin
MAO
cases
serum
of
pharmacy
slowed
if
:

administeredtopically,orally,intramuscularly,orintravenously,depending onthespecificinfectionand
theconditionofthepatient.
The most common adverse effects occurring with most antibiotics are nausea, vomiting, diarrhea,
rashes, allergic reactions, and urticaria. Patients taking antibiotic therapy, especially for a prolonged
duration,candevelopfungalinfectionssuchasvaginalcandidiasisorthrush.
A less common but potentially life-threatening adverse effect of antibiotic therapy is
pseudomembranouscolitis.Thiscausesseverediarrheaandistheresultofovergrowthofthebacterium
Clostridiumdifficile. Anaphylaxis andseizures (especiallywhenhighdosesofbeta-lactamantibiotics
are used) mayalso occur. To minimize the riskoftheseevents, a thoroughpatient historyis essential
beforeprescribingthesedrugs.Therearealsopotentiallymanyinteractionsbetweenantibioticsandother
medications a patient might be taking. Since antibiotics are not without risk, it is important to limit
durationtotheshortesteffectivecourse.Antibiotictherapyshouldbenarrowedtocoverthepathogenic
organism when possible to limit adverse effects, save costs, and reduce development of resistance
organisms.
Broad-SpectrumPenicillins
MostskininfectionsarecausedbyGASandS.aureus.Inthepast,therapywithpenicillinwasusually
effective intreatingthese infections.Withthegrowingproblemof antibiotic resistance,however,it is
now necessaryto choosea broad-spectrum agent.For example,manystrainsofS.aureus producethe
enzyme penicillinase,whichcaninactivatepenicillin.Inthiscase,theprovidershouldchooseanagent
that is penicillinase resistant. Useful agents in this class for treating specific skin infections include
amoxicillin–clavulanate (Augmentin) or dicloxacillin (Dynapen). Penicillin usually still has good
coverageofGAS,butlocalresistancepatternsshouldbecheckedtoshowsusceptibility.
Amoxicillin–clavulanate has bactericidal action against many organisms, including beta-hemolytic
streptococci,S.aureus,E.coli,andProteusmirabilis(P.mirabilis).Theclavulanateportionofthedrug
is a beta-lactamase inhibitor that allows amoxicillin to remain active inthe presence of certain betalactamase enzymes such as the penicillinase produced by S. aureus. Amoxicillin–clavulanate is well
absorbedorallyandismoreresistanttoacidinactivationthanotherpenicillins.
Commonside effectsarenausea,vomiting, diarrhea,rash,andurticaria.Patientswhoare allergicto
penicillinshouldnotbegiventhisagent,anditneedsdoseadjustmentswhenusedinpatientswithrenal
dysfunction.
Dicloxacillin has bactericidal activity against penicillinase-producing strains of S. aureus. It is
administered orally,andthe adverse effect profile is similar to that of amoxicillin– clavulanate. It is
dosedfourtimesdaily,whichmaybemoredifficulttocomplywiththanamoxicillin–clavulanate,which
isdosedtwicedaily(seeTable13.4).
First-GenerationCephalosporins
In this class, commonly used drugs for treating skin infections are cephalexin (Keflex) and cefazolin
(Ancef). These agents have bactericidal activity against many organisms, including GAS and
penicillinase-producing S. aureus. They also have activity against Klebsiella pneumoniae (K.
pneumoniae),P.mirabilis,andE.coli.
Cephalexin is administeredorally andhas excellentbioavailability, while cefazolin isadministered
intravenously.Theiradverseeffectprofilesaresimilartothoseofthebroad-spectrumpenicillins.These

drugs should not be used in patients with a severe penicillin or cephalosporin allergy, and dosage
adjustmentsarenecessaryinpatientswithrenalinsufficiency(seeTable13.4).
Second-GenerationCephalosporins
Second-generation cephalosporins that are useful for skin infections include cefaclor (Ceclor),
cefuroxime (Ceftin, Zinacef), andcefprozil (Cefzil).They are effective against the same organisms as
first-generation cephalosporins but have additional activity against certain gram-negative organisms,
including Haemophilus influenzae (H. influenzae), E. coli, K. pneumoniae, and Proteus organisms.
Theseagentsareallwellabsorbedorallyandtheiradverseeffectprofilesaresimilartothoseofthefirstgenerationcephalosporins.Theyshouldnotbegiventopatientswhohaveasevereallergytopenicillinor
anallergytoothercephalosporins.Dosageadjustmentsarenecessaryinpatientswithrenalinsufficiency
(seeTable13.4).
Third-GenerationCephalosporins
Useful third-generation cephalosporins for treating skin infections include cefpodoxime (Vantin),
ceftriaxone (Rocephin), and ceftazidime (Fortaz). These drugs are usually reserved for more serious
infectionsandarenottypicallychosenasfirst-lineagents.Inaddition,ceftriaxoneandceftazidimearenot
availableasoralagents.Cefpodoximeisavailableonlyasanoralagent.
The spectrum of antibacterial activity for these agents is similar to that of the second-generation
cephalosporins. However, theyare less effective against S. aureus andmore effective against certain
gram-negative organisms, includingEnterobacter,H. influenzae, E.coli,K. pneumoniae,andProteus
species.CeftazidimeistheonlyagentinthisgroupthatcanberecommendedforinfectionscausedbyP.
aeruginosa. Ceftriaxone is absorbed intramuscularly, but this route of administration may be painful.
Cefpodoximeiswellabsorbedorallywhentakenwithfood,althoughabsorptionislessthanthatoforal
first-generationcephalosporins.
Theadverseeffectprofile fortheseagentsissimilar to thatoftheother cephalosporins andbroadspectrumpenicillins.
Theseantibioticsneedtoberenallyadjustedinpatientswithrenaldysfunction,withtheexceptionfor
ceftriaxone. Caution should be used before administering these medications to patients with severe
penicillin or cephalosporin allergies and generally should be avoided. Rarely, ceftriaxone may cause
pseudolithiasis(seeTable13.4).
Clindamycin
Clindamycin(Cleocin)isanalternativeagentthatcanbeconsideredfortreatingbacterialskininfections
duetoS.aureusandGASwhenpatientsareallergictopenicillinsandcephalosporins.Susceptibilityto
S.aureusincludingMRSAmaybelow,andtheclinicianshouldcheckthiswiththelocalantibiogram,if
available.Inaddition,clindamycinmaybeconsideredwhengram-positiveanaerobicbacterialcoverage
isnecessaryforpolymicrobialinfections.
Clindamycinisavailablefororalor IV administrationandisgenerallywelltolerated.Commonside
effects include diarrhea, nausea, and abdominal pain. Also, this agent has been more commonly
associatedwithC.difficile–associatedpseudomembranouscolitis.

Fluoroquinolones
Levofloxacin (Levaquin), moxifloxacin (Avelox), and ciprofloxacin (Cipro) are the fluoroquinolone
antibioticsusedinthetreatmentofskinandskinstructureinfections.Theyareusefulforseriousinfections
in patients with penicillin allergies that have infections caused by gram-negative organisms. Their
spectrumofactivityincludesmanygram-negativebacteria,suchasE.coli,Klebsiella,andEnterobacter
species. In addition, levofloxacin and ciprofloxacin are active against P. aeruginosa. Each
fluoroquinoloneagentisavailableIVandorallyandeachhasexcellentbioavailability.
Commonadverse effectsare diarrhea,nausea, abdominalpain,dizziness,drowsiness,headache,and
insomnia. Uncommon but severe events include Stevens-Johnson syndrome, seizures, Achilles tendon
rupture,andpseudomembranouscolitis.Inaddition,therehavebeenseveralblackboxwarningsissued
bytheFoodandDrugAdministration(FDA)regardingseriousadverseeffectssuchastendinitis,tendon
rupture,peripheralneuropathy,centralnervoussystem(CNS)effects,andaorticrupturesortears.These
agentsshouldbeusedaslast-linetherapy.Fluroquinolonesalsohaveseveraldruginteractions(seeTable
13.4).
Fluoroquinoloneantibioticsarenotrecommendedinchildrenyoungerthanage18orduringpregnancy
and lactation. They are also contraindicated in patients allergic to other fluoroquinolones. These
medicationsshouldbeusedcautiouslyinolderadultsandpatientswithCNSdiseases,seizuredisorders,
orrenalimpairment.
AdditionalAntimicrobialAgents
Vancomycin,daptomycin,telavancin,dalbavancin,oritavancin,linezolid,tedizolid,andtigecyclinehave
antibacterial activity against drug-resistant, gram-positive pathogens including MRSA. Vancomycin
remains the drug of choice for bacterial skin infections due to MRSA when parenteral therapy is
necessary; however, daptomycin, telavancin, dalbavancin, oritavancin, linezolid, tedizolid, and
tigecyclinearealsoeffectivebutaremoreexpensiveoptions.Dalbavancinandoritavancinareuniquedue
totheir verylong half-lives. As a result, treatment withdalbavancinrequires onlytwo dosesgiven1
weekapart,while oritavancinisindicatedtotreatbacterialskininfectionsusingonlyasingleIVdose.
Linezolid and tedizolid are the only agents in this group thatare available orally,which provides an
option for clinicianstoswitchfrom IVto oral therapy when patientsare clinicallystable but require
additional treatment. Linezolid should not be continued for more than 14 days due to the increased
incidenceofdevelopingseriousadverseeffects.Tedizolidisoftenusedfor6daysmaximumfora skin
andsofttissueinfection,butitisveryexpensiveandoftenreservedforspecialcasesneedinginfectious
diseasesconsultation.
DespitetheiractivityagainstMRSA,eachagenthassignificantsideeffects,andthepotentialfordrug–
druginteractionsshouldbeconsideredpriortoinitiatingtherapy.
Sulfamethoxazole–Trimethoprim
Sulfamethoxazole–trimethoprim (SMX–TMP) is another useful agent for the treatment of MRSA
infectionsthatcanbe managedwithoraltherapy.Itis important,however,to rememberthatthisagent
doesnothavereliableactivityforinfectionscausedbyGAS.Therefore,thediagnosisofMRSAshould
bemadepriortotreatment.
Adverse effects associated withSMX–TMPincludegastrointestinal (GI) intolerance,rash, pruritus,

andhyperkale–mia.Inaddition,thisagentmaycausephotosensitivity,andpatientsshouldbecounseledto
wearsunprotectionduringtherapy.
TopicalAgents
Topicalagentsmaybeusedasfirst-linetreatmentoradjunctivelyinbacterialskininfections.Mupirocin
ointmentiseffectiveagainstS.aureusandsomestreptococcalinfections.
Mupirocinointmentisminimallyabsorbedsystemically.Itismetabolizedbytheskinandusuallywell
tolerated. Adverse effectsarefew butincludeheadache,cough,rhinitis, pharyngitis, upper respiratory
tractcongestion,andtaste perversion withnasal use. Burning, stinging, rash, erythema, or itching can
occurwhenappliedtopically.Mupirocinshouldnotbeusedinpatientswithanallergytothedrugand
shouldnotbeusedwithothernasalproducts.
Thetopicalpreparationofgentamicinisavailableinacreamoranointment.Itisapowerfultopical
agent and is effective againstmany organisms, including GAS, S. aureus, and Pseudomonas species.
Topicalgentamicincanbeusedforavarietyofprimaryandsecondaryskininfections.Itisusuallywell
tolerated,althoughirritationmayoccur.Occasionally,fungalinfectionorovergrowthofnon-susceptible
bacteriamayoccuratthesiteofuse.
SelectingtheMostAppropriateAgent
Practice guidelinesareavailable toassistcliniciansinthemanagementofskininfectionsincludingthe
selectionofappropriateantimicrobialtherapy(Stevensetal.,2014).Mostbacterialskinconditionsare
treated empirically based on the prescriber’s knowledge of the organisms most likely to cause a
particularinfection(Table13.5).Whentheorganismisnotknown,thepotentialforseriousinfectionis
present, or if the patient is already extremely ill, the prescriber needs to confirm the diagnosis and
organismeitherbyskinbiopsyorbywoundculture.Insuchcases,empirictreatmentbeginswithabroadspectrumagentuntilorganismsusceptibilityisavailableandadiagnosisismade.
Otherimportantfactorsinchoosinganantibioticagentincludepatientallergies,pregnancystatus,renal
andhepaticfunction,andage.Practicalconcernsthataffectcomplianceincludethetasteofthemedication
(especiallyintreatingchildren),itsadverseeffectprofile,howfrequentlyitmustbetaken,andhowmuch
itcosts.Anantibiotic agentmaybe changediftheconditiondoes notimproveorifintolerable effects
impedecomplianceorposeadangertothepatient.Figure13.1givesanoverviewofthedrugselection
process.
First-LineTherapy:ImpetigoandEcthyma
Forminorcasesofbullousandnon-bullousimpetigo,topicalmupirocinointmentappliedtwicedailyfor
5 days is recommended. For other cases of impetigo and ecthyma, an oral antibiotic with S. aureus
coverage is prescribed for 7 days. A broad-spectrum penicillin (e.g., amoxicillin–clavulanate or
dicloxacillin)orafirst-generationcephalosporin(e.g.,cephalexin)isagoodfirstchoice.Incaseswhere
culturesaretakenandgrowGASonly,penicillinisrecommended.IfMRSAissuspectedorconfirmedor
in those with a penicillin allergy, doxycycline, clindamycin, or SMX–TMP may be used. In many
communities,S.aureus hasbecomeresistantto clindamycin. Clinicians needto checkwiththeir local
antibiogramifavailable.Becauseofthedepthofulcerationandchronicnatureofecthyma,healingtakes
weekstomonths,andscarringislikely. Debridementis painfulandnotrecommendedandunnecessary.

When there are outbreaks of streptococcal glomerulonephritis, IV penicillin should be used to help
controlandeliminatenephritogenicGAS.
First-LineTherapy:CellulitisandErysipelas
Treatment for mild non-purulent cellulitis and erysipelas should begin promptly and usually on an
outpatientbasiswithoralantibiotictherapy.AntibioticsshouldcoverGAS.PenicillinVK,amoxicillin–
clavulanate, a cephalosporin such as cephalexin, clindamycin, or dicloxacillin would be acceptable
options. Clindamycin should be reserved for those with a penicillin allergy. For those with mild
infections caused by MRSA, oral options include SMX–TMP, a tetracycline such as doxycycline or
minocycline,orlinezolid(Sartellietal.,2018).Treatmentdurationistypicallyfor5days,whichmaybe
extendedifthereisnoimprovement.
Those with moderate cellulitis require parenteral therapy with penicillin, cefazolin, ceftriaxone, or
clindamycin. For infections caused by MRSA, IV vancomycin, daptomycin, linezolid, ceftaroline, or
dalbavancin can be used. Most commonly, IV vancomycin is used and these other agents are often
reservedforinfectiousdiseasesspecialistsforspecialandcomplicatedcases.Severeinfectionsrequire
emergency surgical inspection to rule out necrotizing infection. Broad-spectrum empiric antibiotic
treatmentshouldbeinitiatedwithvancomycinandpiperacillin–tazobactam.Improvementusuallyoccurs
rapidlywithinthefirst48hours.
Second-LineTherapy:CellulitisandErysipelas
Iftheinfectiondoesnotrespondtotheinitialcourseoftreatment,patientsshouldbepromptlyreferredor
admittedforIVtherapy.Woundsthatbecomesecondarilyinfectedmayrequiredebridement,withfrequent
cleansinganddressingchanges.Surgicaldebridementmaybenecessary.
First-LineTherapy:PurulentSkinInfections
Inallcasesofpurulentskininfectionssuchasabscesses,furuncles,andcarbuncles,incisionanddrainage
areindicated.Inmildcases,antibioticsareusuallynotneededsincesourcecontrolhasbeenobtainedand
no systemic signs of infection are present. In moderate cases, systemic signs are present andempiric
therapywithSMX–TMPordoxycyclineshouldbestarted.Iftreatmentfails,itisthenconsideredasevere
infection. Additionally, patients who present with fever, tachycardia, tachypnea, leukopenia, or
leukocytosis or are immunocompromised should be treated as patients with severe infection. IV
antibiotics withMRSA coveragesuchas vancomycin,daptomycin,linezolid,telavancin,orceftaroline
shouldbe started. Pus obtainedfromincisionanddrainageinmoderate tosevere infectionsshouldbe
cultured.Oncetheculturespeciatesandsensitivitiesareavailable,antibiotictherapyshouldbenarrowed
as appropriate. In moderate infections, oral therapy with SMX–TMP for MRSA, or cephalexin or
dicloxacillin for methicillin-susceptible Staphylococcus aureus (MSSA), may be used. In severe
infections,de-escalationtocefazolin,nafcillin,oroxacillinmaybedoneifMSSAiscultured.Antibiotics
shouldbegivenfor7to14daysforsevereinfections.
TABLE13.5
RecommendedOrderofTreatmentforBacterialSkinInfections

Infection First-LineTherapy Second-LineTherapy
Minorbullousand
nonbullousimpetigo
TopicalmupirocinBID×5days Oralantibiotic×7daysorrefertoan
Infectiousdiseasesspecialist
Impetigoandecthyma Oralantibiotic×7days AdmitforIVantibiotictreatmentorrefer
Cellulitisanderysipelas Oralantibiotic×5days AdmitforIVantibiotictreatmentorrefer
Furunclesand
carbuncles
Incisionanddrainage.Oralantibiotic×7days
ifinfectioussymptomsnoted
Alternateoralantibioticorrefer
IV,Intravenous.
FIGURE 13–1 Treatment algorithm for impetigo, cellulitis, erysipelas, and other bacterial skin
infections.
Note:Ifthepatienthasnecrotizingfasciitis,admittohospitalandrefertospecialist.
Systemictherapy is notneeded for folliculitis, and it oftenheals withouttreatment in7 to10 days.
Topicalmupirocinorclindamycinmaybeusedincasesofwidespreaddisease.Moistheatapplications

canhelpdrainthepusinfolliculitisandmildfurunculosis.
Forpatientswithparonychia,soakingthefingerortoeinwarmwaterhelpswithspontaneousdrainage.
For paronychias withabscesses or felons, incision and drainage is recommended. Antibiotics are not
recommendedifnosystemsignsofinfectionarepresent.
Second-LineTherapy:PurulentSkinTissueInfections
Forskininfectionsthatfailoraltherapy,IVtherapyshouldbeconsidered.Additionally,recurrenceofa
pustular infection in the samelocation should prompt a workup for a differential diagnosis suchas a
pilonidalcystorotherdermatologicdisease.
First-LineTherapy:DiabeticFootInfections
Forulcersthatarenotinfected,antibioticsarenotrecommended.FormildtomoderateDFIs,patientscan
betreatedintheoutpatientsettingwithoralantibioticscoveringS.aureusandStreptococcusiftheyhave
notrecentlyreceivedantibiotics,inthepastmonth.Suchantibioticsincludecephalexinandamoxicillin–
clavulanate.PatientswithsevereDFIswillrequireinpatientadmissionandinitiationofbroad-spectrum
parenteralantibiotics.SomepatientswithmoderateinfectionsbutwithcertainriskfactorslikePADmay
beinitiallytreatedasthosewithsevereinfections.Additionally,patientswhofailoutpatienttherapymay
needtobeadmittedtoahospitalforparenteralantibioticsandfurtherworkup.
Empiric antibiotic coverage for pseudomonas is often unnecessary unless there are risk factors for
pseudomonasinfection,suchas warmclimate,highlocalprevalence,or walkingbarefootinbodiesof
water (Lipsky et al., 2012). Empiric coverage for MRSAshould be initiated in patients withsevereappearing infection or prior history of MRSA infection or in areas where prevalence of MRSA
colonizationorinfectionishigh.Patientswhohavereceivedantibioticsinthepastmonthshouldreceive
antibioticcoverageagainstgram-negativebacilli.Coverageofanaerobicbacteriamaybeneededincases
ofsevereDFIs.
Antibiotictherapyshouldbenarrowedonceculturesresultandsusceptibilitiesareavailable.Formild
andmoderateDFIs,1to2weeksoftherapyistypicallysufficientandcanbestoppedonceclinicalsigns
ofinfectionareresolved.Forpatientswhohaveboneinvolvement,a4-to-6-weekcourseofantibioticsis
recommended(Boultonetal.,2018).Antibiotic therapywithoutappropriatewoundcare isinsufficient.
Woundcarespecialistsshouldbe consultedifneededandavailable. For anyDFIwithnecrotictissue,
debridementshouldbeperformed.
First-LineTherapy:NecrotizingFasciitis
Surgical debridement is needed emergently for the treatment of necrotizing fasciitis. Additional
debridement isusuallyrequired tofully removeall necrotic tissue. Broad-spectrum empiric antibiotic
therapyshouldbestarted.Anexampleofanempiricantibioticregimenfornecrotizingfasciitisincludes
piperacillin–tazobactam, clindamycin, or vancomycin. Clindamycin is primarily used for its toxin and
cytokinesuppressing properties. Once culture results are available, antibiotic therapy can be tailored
appropriately. Antibioticsarecontinued for 48 to72 hoursafterclinical stability andwhennofurther
proceduresareneeded.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
